Recently Added |View More
News
Myeloma Experts Uncover Key Role for Neutrophils, Potential New Treatment Strategy
Research shows that blocking CXCR2 receptor reduced tumor growth and improved survival; clinical trial underway.
News
Drug application in review based on trial co-led by Roswell Park’s Dr. Eunice Wang in patients with NPM1-mutant AML.
Symposium
This two-day symposium and lecture series presented an engaging and interactive forum to discuss the latest advances in the fields of benign, malignant and classical hematology and includes speakers from Roswell Park Comprehensive Cancer ...
News
Phase 1 Clinical Trial Offers FDA Fast-Tracked Drug for Relapsed/Refractory AML and MDS
A phase 1 clinical trial underway at Roswell Park Comprehensive Cancer Center offers a promising treatment option for patients with relapsed or refractory acute myeloid leukemia (AML) or myelodysplastic syndromes (MDS).
Video
Clinical CAR T-cell Trial for Multiple Myeloma Suggests Possible “Cure”
For the first time, patients on a new CAR T-cell therapy for multiple myeloma are experiencing remission long enough to be cautious deemed cured of their disease.
Video
Cellular Therapies Leading to New Treatment Options for Lymphoma Patients
A new CAR T-cell consortium, Matthew Cortese, MD, MPH, a hematologic oncologist at Roswell Park Comprehensive Cancer Center, shares that certain types of hard-to-treat lymphomas may be more receptive to immunotherapies than previously thought.
News
A meta-analysis led by a researcher at Roswell Park Comprehensive Cancer Center has identified key factors that could improve outcomes for cancer patients treated with immune checkpoint inhibitors (ICIs) before or after a solid-organ transplant.
News
Experts from Roswell Park Comprehensive Cancer Center will give remarks on racial and ethnic disparities in outcomes among people with metastatic breast cancer; risk patterns for second cancers associated with human papillomavirus (HPV); ...
News
Roswell Park presentations include findings from KOMET-001 in AML, new insights on risk of organ rejection after ICI.
This site is intended for healthcare professionals
Click your preferred app store below to download our free mobile app — exclusively for physicians and physician offices — for direct access to a complete, up-to-date directory of Roswell Park physicians wherever you go. Email or call to refer a patient or ask a question with a click of a button.
BROADCASTMED